What is GLP 1 and GIP? Dual action weight loss (UK) PrivateDoc PrivateDoc GLP1 GIP receptor co agonists: a promising evolution in the treatment of type 2 diabetes Acta Diabetologica Springer Nature Link GIP mediates the incretin effect and glucose tolerance by dual actions on cells and cells Science Advances Best of #DiabetesSpectrumADA2024 #15 ALTMETRIC Future Medications for Obesity and Clinical Implications W. Timothy Garvey https: t.co NDfQJbamyd Glucagon like Peptide 1, Glucose Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination